Syqe Medical

📍 Tel Aviv, Israel🗓 Founded 2011👥 105 employees💰 Last funded Nov 2018
Biotechnology Research🌐 syqe.com
Website LinkedIn
Syqe’s mission to accelerate delivery of the most effective medicine, to the largest number of patients, through an advanced administration platform adhering to pharmaceutical standards. Our robust inhalation system is designed to deliver a wide range of drugs - from raw phyto-substances to pharmaceutical substances, targeting cannabis as 1st candidate and becoming the standard of care for medical cannabis. The Syqe inhaler is the world’s first regulatory approved medical device preloaded with a controlled substance. Based in Tel Aviv, Syqe is committed to best-in-class in performance, reliability, and safety. Syqe continues to innovate and scale with the goal of redefining the standard of care and delivering the most effective treatment to patients.
3
Total investors
0
Early stage
1
Mid stage
2
Late stage
2011
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
Israel
1
Investor activity2015–2018 · investors recorded per year
2015120182
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Syqe Medical?
Syqe Medical has 3 investors on record on gritt.io, 1 mid-stage and 2 late-stage investors.
When did Syqe Medical last raise funding?
The most recent investment in Syqe Medical recorded on gritt.io was in November 2018.
When was Syqe Medical founded?
Syqe Medical was founded in 2011.
What industry is Syqe Medical in?
Syqe Medical operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Syqe Medical based?
Syqe Medical is headquartered in Tel Aviv, Israel.